Canadian Cancer Trials Group Bulletins

General


Recent Publications

There were three recent publications -- one related to Canadian Cancer Trials Group MA.22 and two others from the Early Breast Cancer Trialists' Collaborative Group (EBCTCG).

Canadian Cancer Trials Group MA.22 - A Phase I/II Study of Increasing Doses of Epirubicin and Docetaxel Plus Pegfilgrastim for Locally Advanced Or Inflammatory Breast Cancer

Pritzker K, Pritzker L, Generali D, Bottini A, Cappelletti MR, Guo B, Parissenti A, Trudeau M. RNA Disruption and Drug Response in Breast Cancer Primary Systemic Therapy. JNCI Monographs 2015: 76-80, 2015.

http://jncimono.oxfordjournals.org/content/2015/51/76.full
____________________________________

EBCTCG. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. The Lancet 386: 1341-52, 2015.

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2961074-1/fulltext


EBCTCG. Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. The Lancet 386: 1353-61, 2015.

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2960908-4/fulltext